Cerebrospinal Fluid Biomarkers for the Diagnosis of Prodromal Alzheimer’s Disease in Amnestic Mild Cognitive Impairment
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Cerebrospinal Fluid Biomarkers for the Diagnosis of Prodromal Alzheimer’s Disease in Amnestic Mild Cognitive Impairment ; volume:9 ; number:1 ; year:2019 ; pages:100-113
Dementia and geriatric cognitive disorders / Extra. Extra ; 9, Heft 1 (2019), 100-113
- Creator
-
Park, Jung Eun
Choi, Kyu Yeong
Kim, Byeong C.
Choi, Seong-Min
Song, Min-Kyung
Lee, Jang Jae
Kim, Jahae
Song, Ho-Chun
Kim, Hoo-Won
Ha, Jung-Min
Seo, Eun Hyun
Song, Woo Keun
Park, Sung-Gyoo
Lee, Jung Sup
Lee, Kun Ho
- DOI
-
10.1159/000496920
- URN
-
urn:nbn:de:101:1-2019061300170025569562
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:55 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Park, Jung Eun
- Choi, Kyu Yeong
- Kim, Byeong C.
- Choi, Seong-Min
- Song, Min-Kyung
- Lee, Jang Jae
- Kim, Jahae
- Song, Ho-Chun
- Kim, Hoo-Won
- Ha, Jung-Min
- Seo, Eun Hyun
- Song, Woo Keun
- Park, Sung-Gyoo
- Lee, Jung Sup
- Lee, Kun Ho
Other Objects (12)
EEG biomarkers in Alzheimer’s and prodromal Alzheimer’s: a comprehensive analysis of spectral and connectivity features
A deep learning MRI approach outperforms other biomarkers of prodromal Alzheimer’s disease
Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers
Synaptic proteins in CSF as potential novel biomarkers for prognosis in prodromal Alzheimer’s disease
Association of oxidative stress and inflammatory metabolites with Alzheimer’s disease cerebrospinal fluid biomarkers in mild cognitive impairment
Brainstem substructures and cognition in prodromal Alzheimer’s disease
Diagnostic and progression biomarkers in cerebrospinal fluid of Alzheimer’s disease patients
Cost-effectiveness of cerebrospinal biomarkers for the diagnosis of Alzheimer’s disease
Davunetide sex-dependently boosts memory in prodromal Alzheimer’s disease
Differentiating Prodromal Dementia with Lewy Bodies from Prodromal Alzheimer’s Disease: A Pragmatic Review for Clinicians
Conflicting cerebrospinal fluid biomarkers and progression to dementia due to Alzheimer’s disease
Race modifies the relationship between cognition and Alzheimer’s disease cerebrospinal fluid biomarkers
EEG biomarkers in Alzheimer’s and prodromal Alzheimer’s: a comprehensive analysis of spectral and connectivity features
A deep learning MRI approach outperforms other biomarkers of prodromal Alzheimer’s disease
Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers
Synaptic proteins in CSF as potential novel biomarkers for prognosis in prodromal Alzheimer’s disease
Association of oxidative stress and inflammatory metabolites with Alzheimer’s disease cerebrospinal fluid biomarkers in mild cognitive impairment
Brainstem substructures and cognition in prodromal Alzheimer’s disease
Diagnostic and progression biomarkers in cerebrospinal fluid of Alzheimer’s disease patients
Cost-effectiveness of cerebrospinal biomarkers for the diagnosis of Alzheimer’s disease
Davunetide sex-dependently boosts memory in prodromal Alzheimer’s disease
Differentiating Prodromal Dementia with Lewy Bodies from Prodromal Alzheimer’s Disease: A Pragmatic Review for Clinicians
Conflicting cerebrospinal fluid biomarkers and progression to dementia due to Alzheimer’s disease
Race modifies the relationship between cognition and Alzheimer’s disease cerebrospinal fluid biomarkers
EEG biomarkers in Alzheimer’s and prodromal Alzheimer’s: a comprehensive analysis of spectral and connectivity features
A deep learning MRI approach outperforms other biomarkers of prodromal Alzheimer’s disease
Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers
Synaptic proteins in CSF as potential novel biomarkers for prognosis in prodromal Alzheimer’s disease
Association of oxidative stress and inflammatory metabolites with Alzheimer’s disease cerebrospinal fluid biomarkers in mild cognitive impairment
Brainstem substructures and cognition in prodromal Alzheimer’s disease
Diagnostic and progression biomarkers in cerebrospinal fluid of Alzheimer’s disease patients
Cost-effectiveness of cerebrospinal biomarkers for the diagnosis of Alzheimer’s disease
Davunetide sex-dependently boosts memory in prodromal Alzheimer’s disease
Differentiating Prodromal Dementia with Lewy Bodies from Prodromal Alzheimer’s Disease: A Pragmatic Review for Clinicians
Conflicting cerebrospinal fluid biomarkers and progression to dementia due to Alzheimer’s disease